Lymphadenopathy diagnostic criteria

Lymphadenopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphadenopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphadenopathy diagnostic criteria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphadenopathy diagnostic criteria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphadenopathy diagnostic criteria
CDC on Lymphadenopathy diagnostic criteria
Lymphadenopathy diagnostic criteria in the news
Blogs on Lymphadenopathy diagnostic criteria
Directions to Hospitals Treating Lymphadenopathy
Risk calculators and risk factors for Lymphadenopathy diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2]

Overview

Diagnostic criteria for malignant lymphadenopathy, may include: size of node more than 2 cm, node that is draining, hard, or fixed to underlying tissue, atypical location (e.g. supraclavicular node), associated risk factors (e.g. HIV or TB), fever and/or weight loss, and splenomegaly. On the other hand, diagnostic criteria for benign lymphadenopathy, may include: node < 1 cm, node that is mobile, soft-or tender, and is not fixed to underlying tissue, typical location (e.g. supraclavicular node), no associated risk factors, and palpable and painful enlargement.

Diagnostic Criteria

Malignant Lymphadenopathy

• Node > 2 cm
• Node that is draining, hard, or fixed to underlying tissue
• Atypical location (e.g. supraclavicular node)
• Risk factors (e.g. HIV or TB)
• Fever and/or weight loss
• Splenomegaly

Benign Lymphadenopathy

• Node < 1 cm
• Node that is mobile, soft-or tender, and is not fixed to underlying tissue
• Common location (e.g. supraclavicular node)
• No associated risk factors
• Palpable and painful enlargement